Selected article for: "antiviral drug and mechanical ventilation"
Author: Yatomi, Masakiyo; Takazawa, Tomonori; Yanagisawa, Kunio; Kanamoto, Masafumi; Matsui, Yusuke; Tsukagoshi, Hiroyuki; Saruki, Nobuhiro; Saito, Shigeru; Tokue, Yutaka; Maeno, Toshitaka
Title: Improvement of Severe COVID-19 in an Elderly Man by Sequential Use of Antiviral Drugs
  • Cord-id: fr0n9dkg
  • Document date: 2020_9_5
    • ID: fr0n9dkg
    Snippet: Although a variety of existing drugs are being tested for patients with coronavirus disease 2019 (COVID-19), no efficacious treatment has been found so far, particularly for severe cases. We report successful recovery in an elderly patient with severe pneumonia requiring mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Despite administration of multiple antiviral drugs, including lopinavir/ritonavir, chloroquine, and favipiravir, the patient's condition did not improve. How
    Document: Although a variety of existing drugs are being tested for patients with coronavirus disease 2019 (COVID-19), no efficacious treatment has been found so far, particularly for severe cases. We report successful recovery in an elderly patient with severe pneumonia requiring mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Despite administration of multiple antiviral drugs, including lopinavir/ritonavir, chloroquine, and favipiravir, the patient's condition did not improve. However, after administration of another antiviral drug, remdesivir, we were able to terminate invasive interventions, including ECMO, and subsequently obtained negative polymerase chain reaction results. Although further validation is needed, remdesivir might be effective in treating COVID-19.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and administration prevent: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome and admission time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and admission time dyspnea: 1, 2
    • acute respiratory syndrome and liver bacterial infection: 1
    • acute respiratory syndrome and liver dysfunction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and liver dysfunction cause: 1
    • acute respiratory syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lopinavir ritonavir effect: 1, 2, 3, 4
    • acute respiratory syndrome and lopinavir ritonavir oral administration: 1, 2
    • administration method and lopinavir ritonavir: 1, 2
    • admission normal range and lopinavir ritonavir: 1, 2
    • admission time and liver bacterial infection: 1
    • admission time and liver dysfunction: 1, 2, 3, 4, 5
    • admission time and liver dysfunction cause: 1
    • admission time and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • liver dysfunction and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8